Display options
Cite
Breckenridge A, Feldschreiber P. Impact of Brexit on UK and EU Drug Regulation and Patient Access. Clin Pharmacol Ther. 2018;105(4):923-925doi: 10.1002/cpt.1261.
Breckenridge, A., & Feldschreiber, P. (2019). Impact of Brexit on UK and EU Drug Regulation and Patient Access. Clinical pharmacology and therapeutics, 105(4), 923-925. https://doi.org/10.1002/cpt.1261
Breckenridge, Alasdair, and Feldschreiber, Peter. "Impact of Brexit on UK and EU Drug Regulation and Patient Access." Clinical pharmacology and therapeutics vol. 105,4 (2019): 923-925. doi: https://doi.org/10.1002/cpt.1261
Breckenridge A, Feldschreiber P. Impact of Brexit on UK and EU Drug Regulation and Patient Access. Clin Pharmacol Ther. 2019 Apr;105(4):923-925. doi: 10.1002/cpt.1261. Epub 2018 Nov 22. PMID: 30346627.
Copy Download .nbib Format: NLM
Share it on

Clin Pharmacol Ther. 2019 Apr;105(4):923-925. doi: 10.1002/cpt.1261. Epub 2018 Nov 22.

Impact of Brexit on UK and EU Drug Regulation and Patient Access.

Clinical pharmacology and therapeutics

Alasdair Breckenridge, Peter Feldschreiber

Affiliations

  1. Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  2. 4 New Square, Lincoln's Inn, London, UK.

PMID: 30346627 DOI: 10.1002/cpt.1261

Abstract

The chronology of the United Kingdom (UK) leaving the European Union (EU) is presented together with its implications for medicines regulation, including the move of the European Medicines Agency from London (UK) to Amsterdam (the Netherlands). The legal and political options for the UK and the EU are discussed, which at the time of writing (October 2018) are both uncertain. Of importance is the response of the pharmaceutical industry and the possible consequences for UK patients, including delays in access to innovative medicines and an increase in drug costs. Although there may be some possible advantages for UK medicines regulation, these will depend on the outcome of the ongoing negotiations.

© 2018 The Authors Clinical Pharmacology & Therapeutics © 2018 American Society for Clinical Pharmacology and Therapeutics.

MeSH terms

Publication Types